Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Treatment of Atopic Dermatitis and Pruritus
2013-002029-40Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of aprepitant in atopic dermatitis (AD) and pruritus, sponsored by Karolinska Institutet. Primary endpoint: Clinical response after 7–9 days of aprepitant treatment. Started Jun 2013; status: completed.
02
Drugs
aprepitant
03
Conditions
atopic dermatitis (AD)pruritus
Beyond the preview
Go deeper on 2013-002029-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002029-40.